You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

breast cancer triple negative

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant

Not yet recruiting
  • Breast Cancer Triple Negative
  • +3 more
    • Atlanta, Georgia
      Emory University/Winship Cancer Institute
    May 18, 2023

    Triple Negative Breast Tumors Trial (Xiaopi granules, Xiaopi decoction, Placebo)

    Not yet recruiting
    • Triple Negative Breast Neoplasms
    • Xiaopi granules
    • +2 more
    • (no location specified)
    Nov 22, 2023

    Looking At Triple Negative Breast Cancer Patient Experience

    Not yet recruiting
    • Triple Negative Breast Cancer
    • Breast Cancer
      • (no location specified)
      Mar 3, 2023

      Immunotherapy-related CRP Kinetics in Early and Metastatic

      Recruiting
      • TNBC - Triple-Negative Breast Cancer
        • Tuebingen, Germany
          Department of Women's Health
        Jun 13, 2023

        Triple Negative Breast Cancer Trial (Proleukin 1.3 MG Injection)

        Not yet recruiting
        • Triple Negative Breast Cancer
        • Proleukin 1.3 MG Injection
        • (no location specified)
        Apr 6, 2023

        Triple Negative Breast Cancer, Neoadjuvant Chemo, Pembrolizumab Trial in Seoul (Visium, Whole Genome Sequencing(WGS)/Whole

        Recruiting
        • Triple Negative Breast Cancer
        • +3 more
        • Visium, Whole Genome Sequencing(WGS)/Whole Transcriptome Sequencing(WTS)
        • Seoul, Korea, Republic of
          Samsung Medical Center
        Jun 15, 2023

        TNBC - Triple-Negative Breast Cancer Trial in Wuhan (Utidelone, Tirelizumab, Bevacizumab)

        Recruiting
        • TNBC - Triple-Negative Breast Cancer
        • Wuhan, Hubei, China
          Tongji Hospital Affiliated of Tongji Medical College Huazhong Un
        Nov 5, 2023

        Breast Cancer Trial in Beijing (99mTc-MY6349 SPECT/CT scan)

        Recruiting
        • Breast Cancer
        • 99mTc-MY6349 SPECT/CT scan
        • Beijing, Beijing, China
          Peking Union Medical College Hospital
        Oct 24, 2023

        Triple Negative Breast Tumors Trial (Pembrolizumab injection, Capecitabine tablets, Local radiotherapy)

        Not yet recruiting
        • Triple Negative Breast Neoplasms
        • Pembrolizumab injection
        • +2 more
        • (no location specified)
        Jul 25, 2023

        Metastatic Triple-Negative Breast Cancer Trial in Charlotte (Trilaciclib, Pembrolizumab, Gemcitabine)

        Not yet recruiting
        • Metastatic Triple-Negative Breast Cancer
        • Charlotte, North Carolina
          Levine Cancer Institute
        Aug 31, 2023

        Triple Negative Breast Cancer Trial in Dhaka (Doxorubicin, Cyclophosphamide, Paclitaxel)

        Not yet recruiting
        • Triple Negative Breast Cancer
        • Dhaka, Bangladesh
          Bangabandhu Sheikh Mujib Medical University
        May 24, 2023

        Triple Negative Breast Cancer, HER2-positive Breast Cancer Trial in Shanghai (proton plus carbon ion radiotherapy)

        Recruiting
        • Triple Negative Breast Cancer
        • HER2-positive Breast Cancer
        • proton plus carbon ion radiotherapy
        • Shanghai, China
          Shanghai Proton and Heavy Ion center
        Jan 11, 2023

        Metastatic Breast Cancer, Triple Negative Breast Cancer, Estrogen-receptor-low Breast Cancer Trial in Carmel, Indianapolis

        Not yet recruiting
        • Metastatic Breast Cancer
        • +2 more
        • Carmel, Indiana
        • +2 more
        Apr 27, 2023

        Breast Cancer, Triple Negative Breast Cancer Trial (Antivascular therapy, Chemotherapy)

        Not yet recruiting
        • Breast Cancer
        • Triple Negative Breast Cancer
        • (no location specified)
        Jun 11, 2023

        Breast Cancer, Triple Negative Breast Cancer Trial in Gothenburg (Imatinib 400 MG Oral Tablet)

        Not yet recruiting
        • Breast Cancer
        • Triple Negative Breast Cancer
        • Imatinib 400 MG Oral Tablet
        • Gothenburg, Sweden
          Barbro Linderholm
        Feb 1, 2023

        Triple Negative Breast Tumors Trial in Paris (Atezolizumab + RP1)

        Not yet recruiting
        • Triple Negative Breast Neoplasms
        • Atezolizumab + RP1
        • Paris, France
          Institut Curie
        Oct 2, 2023

        Triple Negative Breast Cancer, Breast Cancer Stage II, Breast Cancer Stage III Trial in Boston (Implantable Microdevice (IMD))

        Not yet recruiting
        • Triple Negative Breast Cancer
        • +6 more
        • Implantable Microdevice (IMD)
        • Boston, Massachusetts
        • +1 more
        Mar 8, 2023

        Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of

        Not yet recruiting
        • Triple Negative Breast Cancer
        • +2 more
        • Shanghai, Shanghai, China
          Fudan University Shanghai Cancer Center
        Jul 25, 2023

        TNBC - Triple-Negative Breast Cancer Trial (Alkaline Glucosodiene Molecules)

        Not yet recruiting
        • TNBC - Triple-Negative Breast Cancer
        • Alkaline Glucosodiene Molecules
        • (no location specified)
        Jul 14, 2023

        TNBC - Triple-Negative Breast Cancer Trial in Brussels (Ga-PSMA PET/CT)

        Recruiting
        • TNBC - Triple-Negative Breast Cancer
        • Ga-PSMA PET/CT
        • Brussels, Belgium
          Institut Jules Bordet
        Sep 26, 2023

        Checkpoint Inhibitors in Triple Negative Breast

        Recruiting
        • Triple Negative Breast Cancer
        • Whole Genome Sequencing
        • +7 more
        • Barcelona, Spain
          Vall d'Hebron Institute of Oncology
        Jun 20, 2023

        Breast Cancer Stage IV Trial in Vienna (Datopotamab deruxtecan)

        Recruiting
        • Breast Cancer Stage IV
        • Datopotamab deruxtecan
        • Vienna, Austria
          AKH Universitaetsklinikum Vienna, Department f. Internal medicin
        May 19, 2023

        Advanced Triple Negative Breast Cancer Trial in Shantou (SZ011 CAR-NK)

        Not yet recruiting
        • Advanced Triple Negative Breast Cancer
        • SZ011 CAR-NK
        • Shantou, China
          Shantou
        Jan 9, 2023

        Breast Tumors Trial in Hangzhou (Sindilimab, Nab-paclitaxel, Lenvatinib)

        Not yet recruiting
        • Breast Neoplasms
        • Hangzhou, Zhejiang, China
          ZhejiangCH
        Nov 17, 2023

        Breast Cancer, Contrast Enhanced Ultrasound Trial in Hershey (Lumason)

        Not yet recruiting
        • Breast Cancer
        • Contrast Enhanced Ultrasound
        • Hershey, Pennsylvania
          Penn State Health College of Medicine
        Jul 19, 2023